During the last decades, medical research in Iran had experienced an exponential growth rate. [4, 5] Pharmacology and pharmacy, as a major field of medicine, is the most productive research field for Iranian scientists. About 11% of Iran's research publications in medical and health sciences is attributable to the pharmacology and pharmacy. [5] The landscape of the research in pharmacology and pharmacy is essential for policymakers, institutes, universities, and researchers. Although there are few numbers of bibliometrics study of Iran's researches in pharmacology and pharmacy, [6, 7] there is not a report about the highest level of evidence, most-cited articles and topics, and progression of published articles in pharmacology and pharmacy.
This study aims to evaluate research publications affiliated with Iranian researchers in pharmacology and pharmacy through bibliometrics tools and network analysis. We will provide trends of published articles, received citations, publication of the highest level of evidence, networks of international collaboration, and clustering major topics in Iran's researches in pharmacology and pharmacy.
Methods
Through the pharmacology and pharmacy category of Web of Science (WOS) in the Clarivate analytics (formerly ISI), all published articles affiliated with at least an Iranian researcher as an author were retrieved. To ensure retrieving articles in the context of pharmacology and pharmacy, we limited our search strategy to the journals indexed in the Journal Citation Report (JCR) under the category of pharmacology and pharmacy. [8] At first, the ISSN of the journals indexed in the pharmacology and pharmacy category of the WOS was extracted through the JCR 2017. Then, the search algorithm was applied in the search line as follows: IS = ("ISSN of journal 1" OR "ISSN of journal 2" OR … OR "ISSN of journal 261") AND (AD = [Iran]). Besides, a systematized search in the PubMed on December 2018, through the same but modified search strategy used in the WOS, was conducted for extraction of the study types of the articles in pharmacology and pharmacy. Due to some misspecifications of the PubMed filters for determination of the study type, we used a comprehensive, sensitive, and combined search strategy to identify the clinical trials (CT), randomized CTs (RCTs), and systematic reviews and meta-analyses (SRMAs). The search strategy could be found in the Supplementary.
Full records of retrieved articles in the WOS, including author name and affiliation, journal name, citation number, cited references, and keywords, were exported to a plain text file. Furthermore, the rate of international collaboration was calculated. An article with affiliated authors in different countries is considered as an output of international collaboration. After data cleaning, the file was used for network analysis using the VOSviewer version 1.6.9. [9] In the network maps, the size of the bubbles indicates some documents. The bubbles close to each other with the same colors are in the same homogeneous clusters regarding co-occurrence in the documents. The strength of the relationship is indicated by the lines connecting the bubbles. Table 2 ]. However, 86.54% of the published articles in the top journals had an Iranian researcher as the first author; about 77% of them were published in J Control Release (the Netherlands, IF = 7.87) and Aliment Pharm Ther (England, IF = 7.35). Table 3 
Most-cited articles

Network analysis
Coauthorship map of authors in Figure 2 (bottom, right) revealed 5 clusters of 31 authors with minimum of 50 articles that they collaborate. Each bubble indicates an author, and the links connecting the bubbles indicate collaboration in at least one publication. Out of the 30151 unique keywords, the top 5 most frequent keywords in the articles were in vitro (648 times), mice (639 times), oxidative stress (630 times), rat (526 times), and apoptosis (516 times). The five clusters of major topics, denoted by the green, blue, red, purple, and yellow colors, based on the most commonly used terms in the researches related to the pharmacy in the pharmacy and pharmacology field were mapped in Figure 2 (top, right) . Red-colored cluster represented terms related to the drug delivery topic such as "in vitro," "gene delivery," or "design;" purple-colored cluster represented terms related to basic pharmacology (antioxidant activity) such as "anti-bacterial," "essential oil," or "chemical composition;" green-colored cluster represented terms related to oxidative stress such as "liver," "diabetes," or "lipid peroxidation;" blue-colored cluster represented terms related to animal study such as "rat" or "mice;" and yellow-colored cluster represented terms related to molecular aspect of pharmacy such as "apoptosis," "expression," and "cancer."
dIscussIon
The present study is a bibliometrics and network analysis of the research articles published by Iranian authors in the field of pharmacology and pharmacy. This study showed a marked increasing rate of publications and received citations by Iranians in pharmacology and pharmacy. Furthermore, after 2010, the rate of articles in the high-impact journals had a growth. Also, during the recent decade, research articles in the highest level of evidence were more published by Iranians. Zarrindast MR, Dehpour AR, and Abdollahi M were the top 3 authors that produced the highest number of published articles. The top 3 authors based on the H-index were Hosseinzadeh H, Zarrindast MR, and Dehpour AR. Like the previous studies, TUMS was the most productive regarding a total number of published articles (2351 articles), the total number of received citations (28538), and highest H-index (H = 58). [5] [6] [7] Iranian researchers in pharmacology and pharmacy had more collaboration with the USA, England, and Canada. Conducting researches with the international collaborations is needed to keep moving forward in the science and technology. [12, 13] Evidence is not the same. [14] RCTs and SRMs of the RCTs are gold standards in the evidence-based medicine. They are on the top level of evidence hierarchy. [15] The rate of publishing the highest level of evidence, for example, SRM, CTs, and RCTs in pharmacology and pharmacy is growing during the recent decades. Increasing the number of SRMs could be considered as good news for practitioners in pharmacology and pharmacy. However, they are strongly dependent on the CTs and especially RCTs as the inputs. Neglecting production of high-quality original research in the highest level of evidence, for example, RCTs can harm the evidence-based pharmacology and pharmacy over time. [16] In general, CTs are time-consuming and need more cost and expertise. It seems that researchers tended to do SRMs that request lower cost and time, but with more scientific credits such as citation and improving H-index. Over time, this fast way to produce high-quality evidence with fewer resources makes the pharmacology and pharmacy in Iran to be more dependent, hence vulnerable to the CTs as original data published by other countries.
Network clustering indicates the five distinctive clusters of authors with minimum 50 published articles. In the previous studies, it was mentioned that Iranian authors did not tend to expand their research networks. [7] Furthermore, this issue exists among high-level researchers. Expanding the research network could improve the visibility of researches and also provide opportunities for learning or teaching experiences. [6, 7] Most frequent keywords in the articles were in vitro, mice, oxidative stress, rat, and apoptosis. The five major topics of researches in pharmacology and pharmacy were drug delivery, basic pharmacology, oxidative stress, animal study, and molecular aspect of pharmacy. The previous researches did not explore the topics in the published articles in pharmacology and pharmacy.
Our study has some limitations and strengths.
A comprehensive search strategy used in the most popular indexing databases, Clarivate analytics, and PubMed, and providing a report about the highest level of evidence published by Iranians are considered as the strengths. It is worth mentioning that there are potential articles published in the journals indexed in the other databases, for example, Scopus, or the journals in different categories of the sciences, for example, chemistry. Furthermore, all of the indexing databases have some weaknesses regarding the limited coverage of all literature in several fields of the science. Therefore, retrieved articles in the present study might underestimate the whole literature in the pharmacology and pharmacy. It might be mentioned as the limitation of the study.
In conclusion, published articles by Iranian authors in pharmacology and pharmacy are growing progressively. Its growth is regarding quantity and quality.
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